Source:http://linkedlifedata.com/resource/pubmed/id/11431426
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2001-6-29
|
pubmed:abstractText |
CD83 is an inducible glycoprotein expressed predominantly by dendritic cells (DC) and B lymphocytes. Expression of membrane CD83 (mCD83) is widely used as a marker of differentiated/activated DC but its function and ligand(s) are presently unknown. We report the existence of a soluble form of CD83 (sCD83). Using both a sCD83-specific ELISA and Western blotting, we could demonstrate the release of sCD83 by mCD83(+) B cell and Hodgkin's disease-derived cell lines, but not mCD83(-) cells. Inhibition of de novo protein synthesis did not affect the release of sCD83 during short-term (2 h) culture of cell lines although mCD83 expression was significantly reduced, suggesting sCD83 is generated by the release of mCD83. Isolated tonsillar B lymphocytes and monocyte-derived DC, which are mCD83(low), released only low levels of sCD83 during culture. However, the differentiation/activation of these populations both up-regulated mCD83 and increased sCD83 release significantly. Analysis of sera from normal donors demonstrated the presence of low levels (121 +/- 3.6 pg/ml) of circulating sCD83. Further studies utilizing purified sCD83 and the analysis of sCD83 levels in disease may provide clues to the function and ligand(s) of CD83.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/CD83 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulins,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0953-8178
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
959-67
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11431426-Antigens, CD,
pubmed-meshheading:11431426-B-Lymphocytes,
pubmed-meshheading:11431426-Biological Markers,
pubmed-meshheading:11431426-Cell Line, Transformed,
pubmed-meshheading:11431426-Dendritic Cells,
pubmed-meshheading:11431426-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:11431426-Humans,
pubmed-meshheading:11431426-Immunoglobulins,
pubmed-meshheading:11431426-Jurkat Cells,
pubmed-meshheading:11431426-Lymphocyte Activation,
pubmed-meshheading:11431426-Membrane Glycoproteins,
pubmed-meshheading:11431426-Solubility,
pubmed-meshheading:11431426-U937 Cells
|
pubmed:year |
2001
|
pubmed:articleTitle |
A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera.
|
pubmed:affiliation |
Haematology/Immunology Research Group, Christchurch Hospital and Christchurch School of Medicine, Christchurch, New Zealand.
|
pubmed:publicationType |
Journal Article
|